Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-week Open-Label Study of Treatment of Insomnia With Zaleplon in HIV Positive Patients With Comorbid Depression

NCT03489304 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03489304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-week Open-Label Study of Treatment of Insomnia With Zaleplon in HIV Positive Patients With Comorbid Depression
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
April 3, 2014
Completion date
February 4, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical depression, hiv/aids